🔎 Trials Near Me

Beranda › Kanker Paru Non-Sel Kecil › Georgia › Savannah

Uji klinis Kanker Paru Non-Sel Kecil di Savannah, GA

10 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Savannah (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Menerima pesertaFase 3
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauhnya
  • South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT04267848

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Menerima pesertaFase 3
  • Low Country Cancer Care ( Site 0156), Savannah
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07190248

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Menerima pesertaFase 3
  • Lewis Cancer and Research Pavilion ( Site 0063), Savannah
  • Saint Joseph's Candler Health System ( Site 4010), Bluffton · 18 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06312137

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Menerima pesertaFase 3
  • Research Site, Savannah
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06692738

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2/3
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauhnya
  • South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT06616584

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Menerima pesertaFase 3
  • Curtis and Elizabeth Anderson Cancer, Savannah
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT02468024

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Menerima pesertaStudi observasional
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauhnya
  • The Radiation Oncology Center-Hilton Head/Bluffton, Hilton Head Island · 22 mi jauhnya
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Savannah
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Uji klinis Kanker Paru Non-Sel Kecil di kota lain

Studi lain di Savannah

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.